Crescita Therapeutics (TSE:CTX) Trading Up 1.1% – Still a Buy?

Shares of Crescita Therapeutics Inc. (TSE:CTX) were up 1.1% during mid-day trading on Tuesday . The stock traded as high as C$0.45 and last traded at C$0.45. Approximately 21,000 shares changed hands during trading, a decline of 1% from the average daily volume of 21,207 shares. The stock had previously closed at C$0.45.

Crescita Therapeutics Price Performance

The business has a fifty day moving average price of C$0.46 and a 200-day moving average price of C$0.47. The company has a current ratio of 2.70, a quick ratio of 2.29 and a debt-to-equity ratio of 5.77. The stock has a market capitalization of C$8.38 million, a PE ratio of 22.50 and a beta of -0.06.

Crescita Therapeutics (TSE:CTX) last announced its quarterly earnings data on Wednesday, November 5th. The company reported C$0.04 earnings per share for the quarter. The company had revenue of C$5.39 million for the quarter. Crescita Therapeutics had a negative return on equity of 15.60% and a negative net margin of 15.73%.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin.